Back to Search Start Over

bitBiome and Kaken Pharmaceuticals Sign Joint Research Agreement on the Discovery of Drugs for Infectious Diseases

Source :
Plus Company Updates. March 30, 2023
Publication Year :
2023

Abstract

TOKYO, bitBiome, Inc. (Head office: Shinjuku-ku, Tokyo; President: Yuji Suzuki; hereafter bitBiome) and Kaken Pharmaceuticals (Head office: Bunkyo-ku, Tokyo; President: Hiroyuki Horiuchi; hereafter Kaken) have signed a joint research agreement [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.744740956